Skip to main content
Clinical Trials/CTRI/2023/09/057533
CTRI/2023/09/057533
Not yet recruiting
Phase 3

A Comparative Pharmaceutical- Analytical Study of Traditional & Advanced Dosage Form of Raktachandanadi Lepa with Mukta Bhasma and its Clinical Effects in Vyanga. - Nil

Government PG Ayurvedic College And Hospital Varanasi0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L811- Chloasma
Sponsor
Government PG Ayurvedic College And Hospital Varanasi
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Government PG Ayurvedic College And Hospital Varanasi

Eligibility Criteria

Inclusion Criteria

  • Patients suffering from classical clinical signs and symptoms of Vyanga–
  • 1\. Mukhamaagatya mandalam i.e. Circumscribed patches over face.
  • 2\. Tanukam i.e. Unelevated pigmentation of the facial skin.
  • 3\. Shyavam i.e. Dark brown pigmentation of the facial skin.
  • 4\. Neerujam i.e. Painless patches.

Exclusion Criteria

  • Patients having pigmentation other than the face and other Kshudraroga.
  • Pigmentation produced due to side effects of any other drug applied earlier.
  • Patients below 15 years and above 45 years.
  • Individuals suffering from systemic pathologies like SLE, Cancer, Severe Hormonal imbalance etc.
  • Patients on medication of Hormonal Therapy.
  • Pregnant or Breastfeeding mother.
  • Patients having complains of painful pigmented patches.

Outcomes

Primary Outcomes

Not specified

Similar Trials